London:  Doctors on Saturday praised “unprecedentedly strong responses” to an injection that eradicated entire tumours in otherwise treatment-resistant cancer cases during a trial. It shrank the tumours for 42% of patients in the study by the Institute of Cancer Research (ICR), London. Scientists gave amivantamab to people with recurrent and/or metastatic head and neck […]